These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
213 related articles for article (PubMed ID: 8738671)
1. Initial experience with tacrolimus rescue therapy in OKT3 resistant rejection. Herget S; Heemann U; Friedrich J; Kribben A; Wagner K; Philipp T Clin Nephrol; 1996 May; 45(5):352-4. PubMed ID: 8738671 [TBL] [Abstract][Full Text] [Related]
2. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation. Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103 [TBL] [Abstract][Full Text] [Related]
3. Tacrolimus rescue therapy in patients with rejection and long-term dialysis after kidney transplantation. Witzke O; Becker G; Erhard J; Lütkes P; Szabo A; Philipp T; Heemann U Clin Nephrol; 1998 Jan; 49(1):24-7. PubMed ID: 9491282 [TBL] [Abstract][Full Text] [Related]
4. Tacrolimus rescue therapy for children with acute renal transplant rejection. Hymes LC; Warshaw BL Pediatr Nephrol; 2001 Dec; 16(12):990-2. PubMed ID: 11793086 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of tacrolimus compared with cyclosporin A microemulsion in renal transplantation: 2 year follow-up results. Krämer BK; Montagnino G; Del Castillo D; Margreiter R; Sperschneider H; Olbricht CJ; Krüger B; Ortuño J; Köhler H; Kunzendorf U; Stummvoll HK; Tabernero JM; Mühlbacher F; Rivero M; Arias M; Nephrol Dial Transplant; 2005 May; 20(5):968-73. PubMed ID: 15741208 [TBL] [Abstract][Full Text] [Related]
6. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection. Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238 [TBL] [Abstract][Full Text] [Related]
7. Increased early rejection rate after conversion from tacrolimus in kidney and pancreas transplantation. Barone GW; Ketel BL; Abul-Ezz SR; Lightfoot ML JOP; 2002 Mar; 3(2):49-53. PubMed ID: 11884766 [TBL] [Abstract][Full Text] [Related]
9. A retrospective study of conversion from tacrolimus-based to sirolimus-based immunosuppression in orthotopic liver transplant recipients. Yu S; He X; Yang L; Ma Y; Zhu X; Ju W; Huang J Exp Clin Transplant; 2008 Jun; 6(2):113-7. PubMed ID: 18816237 [TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria. Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224 [TBL] [Abstract][Full Text] [Related]
11. FK 506 rescue therapy for hepatic allograft rejection: experience with an aggressive approach. Woodle ES; Perdrizet GA; So SK; White HM; Marsh JW Clin Transplant; 1995 Feb; 9(1):45-52. PubMed ID: 7537988 [TBL] [Abstract][Full Text] [Related]
12. Treatment of steroid-resistant rejection with tacrolimus prior to OKT3 in liver transplant recipients. Millis JM; Bruce DS; Newell KA; Piper JB; Woodle ES; Seaman DS; Baker AL; Hart J; Dasgupta K; Thistlethwaite JR Transplant Proc; 1996 Apr; 28(2):1014. PubMed ID: 8623213 [No Abstract] [Full Text] [Related]
14. Treatment of steroid-resistant and recurrent acute cardiac transplant rejection with a short course of antibody therapy. Cantarovich M; Latter DA; Loertscher R Clin Transplant; 1997 Aug; 11(4):316-21. PubMed ID: 9267721 [TBL] [Abstract][Full Text] [Related]